Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2007
04/04/2007EP1562932B1 4-tetrazolyl-4-phenylpiperidine derivatives for treating pain
04/04/2007EP1549633A4 Nicotine-containing, controlled release composition and method
04/04/2007EP1536797B1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough
04/04/2007EP1465890B1 Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
04/04/2007EP1429607B1 Delta 1-pyrrolines used as pesticides
04/04/2007EP1383501B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists
04/04/2007EP1377556B1 Pyrazole derivatives for treating hiv
04/04/2007EP1362033B1 Pyridine matrix metalloproteinase inhibitors
04/04/2007EP1219609B1 Aromatic nitrogenous six-membered ring compounds
04/04/2007CN1942551A New organic luminescent element
04/04/2007CN1942466A Caspase inhibitors and uses thereof
04/04/2007CN1942465A Akt活性抑制剂 Akt activity inhibitor
04/04/2007CN1942464A Novel piperidine substituted diaminothiazoles
04/04/2007CN1942463A 2-aminopyridine derivative
04/04/2007CN1942450A Process for the preparation of substituted triazole compounds
04/04/2007CN1942449A Process for preparing pyridazinone compounds
04/04/2007CN1942447A Ion channel modulators
04/04/2007CN1942445A Novel quinoline-carbaxamides as JACK3 kinase modulators
04/04/2007CN1942436A Lysine based compounds
04/04/2007CN1942188A Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
04/04/2007CN1942187A 17 beta-acetamide-4-azasteroids as androgen receptor modulators
04/04/2007CN1942186A Pyrrolidine compounds
04/04/2007CN1939916A Compound for treating AIDS
04/04/2007CN1939915A 喹啉衍生物 Quinoline derivatives
04/04/2007CN1939910A Amino-metadiazine compound and its salt, its preparation and pharmaceutical use
04/04/2007CN1939905A Indole acrylic acid derivative and its use for preparing immune inhibitor
04/04/2007CN1939903A Mandelic acid derivatives and their use as throbin inhibitors
04/04/2007CN1939902A Mandelic acid derivatives and their use as throbin inhibitors
04/04/2007CN1939307A 2,4,6-triamino-1,3,5-triazine derivative
04/04/2007CN1308326C Process for preparing indolinone derivatives
04/04/2007CN1308325C Novel aryl-{4-halo-4-[heteroarylmethylamino)-methyl]-piperidin-1-yl}-methanone derivatives, methods for production and use thereof as medicaments
04/04/2007CN1308324C Quinazoline derivatives as alpha-1 adrenergic antagonists
04/04/2007CN1308313C Fused azepine drivatives and their use as antidiuretic agents
04/04/2007CN1308310C Nitrogenous aromatic ring compounds
04/04/2007CN1307997C 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating pulmonary fibrosis
04/04/2007CN1307992C Eye drops containing tetrazole derivative
04/03/2007US7199245 4-imino-n-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators
04/03/2007US7199244 Cyclic amine derivatives and methods of use
04/03/2007US7199243 Antilipemic agents; anticholesterol agents; atherosclerosis; cardiovascular disorders; obesity; antidiabetic agents
04/03/2007US7199240 Reductive alkylation of saturated cyclic amines
04/03/2007US7199147 Rho kinase inhibitors
04/03/2007US7199146 Imidazolidinedione analogs useful as anticoagulants and antithrombotics
04/03/2007US7199140 (bis(Phenoxy or phenylsulfonamido)phenylethyl)pyridyl carboxylic acids, esters or amides; antidiabetic agents; obesity; glucokinase agonists
04/03/2007US7199138 Substituted anthranilamides for controlling invertebrate pests
04/03/2007US7199137 Treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy
04/03/2007US7199136 Antiinflammatory agents, neutrophil elastase inhibitors; chronic obstructive pulmonary diseases
04/03/2007US7199135 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity
04/03/2007US7199134 Hydroxamic acid compounds and methods of use thereof
04/03/2007US7199126 P38 MAP kinase; enzyme inhibitors; antiinflammatory agents; cardiovascular disorders
04/03/2007US7199124 Antiinflammatory agents; antiarthritic agents; immunomoderators
04/03/2007US7199123 Pyrazine compounds as transforming growth factor (TGF) compounds
04/03/2007US7199117 2-(substituted phenyl)imidazo[1,2-a]pyridine compounds; use to treat disorders mediated by the histamine H3 receptor such as sleep disorders, attention deficit hyperactivity disorder, and learning and memory disorders; 2-[4-[4-Pyrrolidinobut-1-ynyl]phenyl]-7-methylimidazo[1,2-a]pyridine for example
04/03/2007CA2288140C Farnesyltransferase inhibiting quinazolinones
04/03/2007CA2236269C Selective .beta.3 adrenergic agonists
04/03/2007CA2149044C Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists
03/2007
03/29/2007WO2007035841A1 Analogs of dehydrophenylahistins and their therapeutic use
03/29/2007WO2007035379A1 Polymorphs of tartrate salt of 2-[2-(3-(r)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6h-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor
03/29/2007WO2007035372A2 Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
03/29/2007WO2007035309A1 Tyrosine kinase inhibitors
03/29/2007WO2007035158A1 Alkyl sulfoxide quinolines as nk-3 receptor ligands
03/29/2007WO2007035003A1 Process for producing optically active piperazine compound
03/29/2007WO2007034846A1 Cardiotonic agent comprising grk inhibitor
03/29/2007WO2007034326A2 Imidazole compounds for the treatment of neurological disorders
03/29/2007WO2007034251A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/29/2007WO2007034144A1 4- (ih-indazol-s-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer
03/29/2007WO2007034143A1 Quinazoline derivatives as anticancer agents
03/29/2007WO2007012849A3 MASS LABELS FOR BIOMOLECULES CONTAINING A 2,6-DIMETHYL-PIPERIDIN-l-YL METHYLENE OR A PYRIMIDIN-2-YL THIOMETHYLENE MASS MARKER MOIETY AND A SUCCINIMID-OXY-CARBONYL REACTIVE FUNCTIONAL GROUP
03/29/2007WO2007005951A3 Stereoisomeric pyridyl and pyridonyl compounds and methods for the treatment of gastrointestinal and central nervous system disorders
03/29/2007WO2007002635A3 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/29/2007WO2006136552A3 Process for the production of intermadiates for the preparation of tricyclic benzimidazoles
03/29/2007WO2006135641A3 PROCESS FOR THE SYNTHESIS OF 5- (METHYL-lH-IMIDAZOL-l-YL) -3- (TRI FLUOROME TH YL) -BENZENEAMINE
03/29/2007WO2006132914A3 Cyclobutyl amine derivatives
03/29/2007WO2006125181A3 Piperidine derivatives and their use as stearoyl-coa desaturase modulators
03/29/2007WO2006124447A3 Substituted n-arylpyrrolidines as selective androgen receptor modulators
03/29/2007WO2006120478A3 Quinoline derivatives as neurokinin receptor antagonists
03/29/2007WO2006108965A3 Npy antagonists, preparation and use
03/29/2007WO2006094799A3 Pyridinone derivatives against malaria
03/29/2007WO2006060424A3 Inducible nitric oxide synthase dimerization inhibitors
03/29/2007WO2006024841A3 Benzamide compounds
03/29/2007WO2005109987A9 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
03/29/2007WO2005092066A8 Imidazole compounds
03/29/2007US20070072913 Thermodynamically stable at room temperature, nonhygroscopic
03/29/2007US20070072912 Alicyclic-amine-substituted 4-carboxamido-benzimidazoles as parp-inhibitors and antioxidants
03/29/2007US20070072911 Indoles and azaindoles as antiviral agents
03/29/2007US20070072909 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
03/29/2007US20070072906 Pyrrole compounds
03/29/2007US20070072901 1-Amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5
03/29/2007US20070072900 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
03/29/2007US20070072874 Aminoheteroaryl compounds as protein kinase inhibitors
03/29/2007US20070072869 CERTAIN GLYCINE DERIVATIVES AS FACTOR Xa INHIBITORS FOR USE IN THE TREATMENT OF THROMBOTIC DISORDERS
03/29/2007US20070072866 that inhibit the metabolic activity of the enzyme glycogen synthase kinase 3 beta (GSK-3 beta), which is believed to cause the neurodegeneration that results in diseases of the central nervous system; enzyme inhibitors
03/29/2007US20070072853 Benzimidazole derivatives compositions containing them, preparation thereof and uses thereof
03/29/2007US20070072850 Pesticides
03/29/2007US20070072842 6-Alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitors
03/29/2007US20070072837 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
03/29/2007US20070072833 Survivin inhibitors
03/29/2007US20070072812 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
03/29/2007US20070071671 Process for producing radioactive-fluorine-labeled compound
03/29/2007US20070071670 Diagnostic imaging agents with mmp inhibitory activity
03/29/2007CA2623312A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands